Pharmazz, Dr Reddy’s enter licensing pact to market Centhaquine in India
Centhaquine is a resuscitative agent to treat hypovolemic shock by increasing stroke volume and cardiac output due to an increase…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Lyfaquin
Centhaquine set to enter US-FDA approved Phase 3 clinical trial in US and Europe
Pharmazz India obtained marketing authorization for the management of Hypovolemic shock Lyfaquin (INN: Centhaquine) in India in…